Global map > Innovations > North America and Caribbean > United States > San Francisco > Ligandal
Ligandal icon
Ligandal is developing pepitide-mimetic vaccines that can trigger T cell and B cell responses to the novel coronavirus, while also serving as competitive inhibitors and drug/gene delivery carriers to target the ACE2 receptor.
Loading startups...